These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 6380350)

  • 1. Double-blind, crossover study of the clinical efficacy and the hemorheological effects of pentoxifylline in patients with occlusive arterial disease of the lower limbs.
    Strano A; Davi G; Avellone G; Novo S; Pinto A
    Angiology; 1984 Jul; 35(7):459-66. PubMed ID: 6380350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Failure of pentoxifylline or cilostazol to improve blood and plasma viscosity, fibrinogen, and erythrocyte deformability in claudication.
    Dawson DL; Zheng Q; Worthy SA; Charles B; Bradley DV
    Angiology; 2002; 53(5):509-20. PubMed ID: 12365857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A controlled trial of pentoxifylline (Trental 400) in intermittent claudication: clinical, haemostatic and rheological effects.
    Reilly DT; Quinton DN; Barrie WW
    N Z Med J; 1987 Jul; 100(828):445-7. PubMed ID: 3330188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Placebo controlled double blind study with pentoxifylline of walking performance in patients with intermittent claudication.
    Di Perri T; Guerrini M
    Angiology; 1983 Jan; 34(1):40-5. PubMed ID: 6824189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies of the clinical pharmacology and therapeutic efficacy of pentoxifylline in peripheral obstructive arterial disease.
    Di Perri T; Carandente O; Vittoria A; Guerrini M; Messa GL
    Angiology; 1984 Jul; 35(7):427-35. PubMed ID: 6540539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pentoxifylline -- a biomedical profile.
    Müller R
    J Med; 1979; 10(5):307-29. PubMed ID: 393789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trental 400 in the treatment of intermittent claudication: results of long-term, placebo-controlled administration.
    Roekaerts F; Deleers L
    Angiology; 1984 Jul; 35(7):396-406. PubMed ID: 6380348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pentoxifylline (Trental)--a new drug for the treatment of peripheral chronic occlusive arterial disease.
    Chopra HK; Chopra KL; Aggarwal KK; Parashar SK
    J Med; 1988; 19(2):89-107. PubMed ID: 3049876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pentoxifylline efficacy in the treatment of intermittent claudication: multicenter controlled double-blind trial with objective assessment of chronic occlusive arterial disease patients.
    Porter JM; Cutler BS; Lee BY; Reich T; Reichle FA; Scogin JT; Strandness DE
    Am Heart J; 1982 Jul; 104(1):66-72. PubMed ID: 7046409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pentoxifylline in the treatment of intermittent claudication of the lower limbs.
    Reich T; Cutler BC; Lee BY; Porter JM; Reichle FA; Scogin JT; Strandness DE
    Angiology; 1984 Jul; 35(7):389-95. PubMed ID: 6380347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemorheological effects of pentoxifylline on disturbed flow behavior of blood in patients with cerebrovascular insufficiency.
    Ott E; Lechner H; Fazekas F
    Eur Neurol; 1983; 22 Suppl 1():105-7. PubMed ID: 6884401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the assessment of the efficacy of pentoxifylline (Trental).
    Rössner M; Müller R
    J Med; 1987; 18(1):1-15. PubMed ID: 3298515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intermittent claudication: a double-blind crossover trial of pentoxifylline.
    Gallus AS; Gleadow F; Dupont P; Walsh J; Morley AA; Wenzel A; Alderman M; Chivers D
    Aust N Z J Med; 1985 Aug; 15(4):402-9. PubMed ID: 3866536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does oxpentifylline ('Trental') have a place in the treatment of intermittent claudication?
    Donaldson DR; Hall TJ; Kester RC; Ramsden CW; Wiggins PA
    Curr Med Res Opin; 1984; 9(1):35-40. PubMed ID: 6373157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pentoxifylline treatment in patients with occlusive peripheral arterial disease. Circulatory changes and effects on prostaglandin synthesis.
    Poggesi L; Scarti L; Boddi M; Masotti G; Serneri GG
    Angiology; 1985 Sep; 36(9):628-37. PubMed ID: 3901827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Intermittent claudication treated with pentoxifylline. A controlled trial].
    Skovborg F; Bonde-Petersen F; Bloch I; Christensen E
    Ugeskr Laeger; 1983 Nov; 145(47):3649-52. PubMed ID: 6362159
    [No Abstract]   [Full Text] [Related]  

  • 17. Pentoxifylline--a new drug for the treatment of intermittent claudication.
    Chopra HK; Chopra KL; Aggarwal KK; Parashar SK
    Indian Heart J; 1989; 41(2):127-33. PubMed ID: 2744799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacology of pentoxifylline, a hemorheologic agent for the treatment of intermittent claudication.
    Aviado DM; Dettelbach HR
    Angiology; 1984 Jul; 35(7):407-17. PubMed ID: 6380349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous treatment of chronic peripheral occlusive arterial disease: a double-blind, placebo-controlled, randomized, multicenter trial of pentoxifylline.
    Rudofsky G; Haussler KF; Künkel HP; Schneider-May H; Spengel F; Symann O; Werner HJ
    Angiology; 1989 Jul; 40(7):639-49. PubMed ID: 2662830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacologic treatment of intermittent claudication.
    Porter JM; Bauer GM
    Surgery; 1982 Dec; 92(6):966-71. PubMed ID: 7147192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.